Shiota Maki, Sano Masayuki, Miyagishi Makoto, Taira Kazunari
Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Tokyo 113-8656.
J Biochem. 2004 Aug;136(2):133-47. doi: 10.1093/jb/mvh119.
Ribozymes are catalytic RNA molecules that cleave RNAs with high specificity. Since the discovery of these non-protein enzymes, the rapidly developing field of ribozymes has been of particular interest because of the potential utility of ribozymes as tools for reversed genetics. However, despite extensive efforts, the activity of ribozymes in vivo has not usually been high enough to achieve the desirable biological effects. Now, by the use of RNA polymerase III (pol III) promoters, the ribozyme activity in cells has been successfully improved by developing efficient transport systems for the transcripts to the cytoplasm. In addition, it is possible to cleave a specific target RNA in cells by using an allosterically controllable ribozyme or an RNA-protein hybrid ribozyme. These ribozymes are potentially applicable to molecular gene therapy and efficient gene discovery systems. Furthermore, the developed pol III expression system is applicable to the expression of small interfering RNAs (siRNAs). The advantage of such ribozymes over siRNAs is the high specificity of the ribozyme that would not cause interferon responses.
核酶是具有催化活性的RNA分子,能高度特异性地切割RNA。自从发现这些非蛋白质酶以来,快速发展的核酶领域因其作为反向遗传学工具的潜在用途而备受关注。然而,尽管付出了巨大努力,核酶在体内的活性通常还不够高,无法实现理想的生物学效应。现在,通过使用RNA聚合酶III(pol III)启动子,通过开发有效的转录本向细胞质的转运系统,细胞中的核酶活性已成功提高。此外,通过使用变构可控核酶或RNA-蛋白质杂交核酶,可以在细胞中切割特定的靶RNA。这些核酶有可能应用于分子基因治疗和高效基因发现系统。此外,开发的pol III表达系统适用于小干扰RNA(siRNA)的表达。这种核酶相对于siRNA的优势在于其高特异性,不会引发干扰素反应。